CTOs on the Move


 
JEOL USA, Inc. is a wholly owned subsidiary of JEOL, Ltd. of Akishima, Japan.JEOL USA, Inc. was incorporated in the United States in 1962, and moved to present corporate offices at 11 Dearborn Road in Peabody, Massachusetts, in August 1979. The primary
  • Number of Employees: 1K-5K
  • Annual Revenue: $100-250 Million

Executives

Name Title Contact Details

Similar Companies

Hyperfine

Hyperfine`s mission is to make MRI accessible to every patient, regardless of income or resources. Anytime. Anywhere. Hyperfine designed the Swoop™ Portable MR Imaging System to overcome patient transport and dedicated room requirements associated with fixed conventional MRI systems. The Swoop™ system plugs into a standard electrical outlet, uses an Apple iPad® for control, and produces images at a patient`s bedside within minutes, allowing care teams to gain clinical information quickly. Fierce Medtech recently recognized Hyperfine as a 2020 Fierce 15 company for its innovative and creative approach to developing solutions for healthcare providers and patients. Hyperfine is part of 4Catalyzer, a portfolio of health technology companies with facilities in Connecticut, New York City, Palo Alto, California, and Taiwan.

NCD Corporation

NCD Corporation is a Eastlake, OH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

AMDR

AMDR is a Washington, DC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Telemedicine Solutions

Telemedicine Solutions is a Hoffman Estates, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Vermillion

Vermillion`s vision is to become a recognized leader in the advancement of women`s health by providing innovative methods to detect, monitor and manage the treatment of gynecologic cancers and other related diseases. We will develop and commercialize high-value, multi-marker, diagnostic tests which address unmet needs in gynecologic oncology and women’s health. We will accomplish our mission through internal development, targeted acquisitions, and collaborations with leading scientific and clinical institutions. Our global commercial efforts will include direct marketing and sales activities as well as partnerships with leading companies in women’s health.